Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12R - Indexing scheme associated with subclasses , relating to micro-organisms › C12R 1 - Micro-organisms
Patents for C12R 1 - Micro-organisms (92,025)
12/1999
12/14/1999US6001618 Haloacetoacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme
12/14/1999US6001605 Dna sequence coding for two cytokines; diagnosing human colon cancer; for detecting antiinflammatory agents
12/14/1999US6001603 Polynucleotide sequence coding for a staphylococcus enzmatic protein; for diagnosis, treatment and prevention of bacterial infections; bactericides
12/14/1999US6001602 DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
12/14/1999US6001601 Methionyl tRNA synthetase polynucleotides
12/14/1999US6001581 Cation-based bioassay using human metabotropic glutamate receptors
12/14/1999US6001564 Using oligionucleotides to determine quanity of nucleic acids; contacting sample with oligonucleotides, detecting hybridized complexes or amplified bacterial products with antibiotic resistance gene; for the detection of parasites
12/14/1999US6001560 Stably-transformed human cell lines containing a human gamma interferon-responsive human hla-dr alpha promoter operatively linked to a reporter gene for use in screening for agonists or antagonists of human gamma interferon
12/14/1999US6001363 Eimeria protein with immunogenic properties; dna encoding this protein can be used for the preparation of a vector vaccine against coccidiosis
12/14/1999US6001358 Useful for treatment of autoimmune diseases
12/14/1999US6001348 An nad (nicotinamide-adenine dinucleotide)-independent live attenuated strain of mycoplasma synoviae; and less expensive vaccines for protecting poultry against mycoplasma synoviae
12/14/1999CA2186526C Method and product for regulating cell responsiveness to external signals
12/14/1999CA2172137C Surface loop structural analogues of fibroblast growth factors
12/14/1999CA2135642C Tat-derived transport polypeptides
12/14/1999CA2117795C Gustducin materials and methods
12/14/1999CA2084186C Purification of human interleukin-4 secreted from a escherichia coli mutant
12/14/1999CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3
12/14/1999CA2058216C Enzymatic process for preparing 7-aminocephalosporanic acid and derivatives
12/14/1999CA2036913C A modified transcription control unit and uses thereof
12/14/1999CA2017767C Anticancer antibiotic mi43-37f11 substance, the production and uses thereof
12/14/1999CA1340852C Process for purifying primate gm-csf protein
12/14/1999CA1340848C Pseudorabies virus protein
12/14/1999CA1340847C Adhesin antigens
12/12/1999CA2272599A1 Rice gene resistant to blast disease
12/09/1999WO1999063106A1 Biotechnological production of polyglutaminic acid
12/09/1999WO1999063102A1 ANTIDIABETIC ACTIVE COMPOUND(S) WF19353 AND PROCESS FOR THEIR FERMENTATIVE PREPARATION USING A FUNGUS OF THE GENUS $i(HELICOMYCES)
12/09/1999WO1999063090A2 Protease inhibitor peptides
12/09/1999WO1999063083A1 Novel gene and protein encoded thereby
12/09/1999WO1999063075A1 Monoclonal antibodies and method for assaying fdp
12/09/1999WO1999062946A1 nrdF
12/09/1999WO1999062549A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999WO1999062348A1 Process for the manufacture of probiotic cheese
12/09/1999WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/09/1999DE19825507A1 Biotechnologische Herstellung von Polyglutaminsäure Biotechnological production of polyglutamic
12/09/1999CA2333975A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999CA2330191A1 Protease inhibitor peptides
12/09/1999CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/08/1999EP0962534A2 Expression vector containing regulatory sequences from an immunoglobulin locus
12/08/1999EP0962529A1 Synthesis of human procollagens and collagens in recombinant DNA systems
12/08/1999EP0962526A2 Method for reversible modification of thermostable enzymes
12/08/1999EP0961833A1 Human plasma hyaluronidase
12/08/1999EP0961831A1 Human endokine alpha
12/08/1999EP0961780A1 Protein markers for lung cancer and use thereof
12/08/1999EP0961778A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
12/08/1999EP0775158B1 Cyclopeptolides
12/08/1999EP0628078B1 Multivalent single chain antibodies
12/08/1999EP0606280B1 New conjugates for the introduction of nucleic acid into higher eukaryotic cells
12/08/1999EP0542931B1 Serine protease variants having peptide ligase activity
12/08/1999EP0493398B1 Alkaline proteolytic enzyme and method of production
12/08/1999CN1238009A Protein engineering method of glucoamylase to increase pH optimum, substrate specificity and thermostability
12/08/1999CN1238008A HPPD gene and inhibitors
12/08/1999CN1237977A High level expression of proteins
12/08/1999CN1237970A Epothilone C. D. E and F, production process, and their use as cytostatic as well as phytosanitary agents
12/08/1999CN1047204C 生产重组人体乳铁蛋白 Production of recombinant human lactoferrin
12/08/1999CN1047202C Process for preparing protein encoded by cephalosporin acetylhydrolase gene
12/07/1999US5998699 Potyvirus coat protein genes and plants transformed therewith
12/07/1999US5998602 RNase L activators and antisense oligonucleotides effective to treat RSV infections
12/07/1999US5998587 Anti-cyanovirin antibody
12/07/1999US5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/07/1999US5998579 Epimorphin antagonist and process for producing it
12/07/1999US5998197 The invention is judged of considerable importance in reducing the substantial amount of downtime caused by pitch deposits and accumulations in the pulp and paper and other industries which convert pulpwoods.
12/07/1999US5998195 Highly-purified recombinant reverse transcriptase
12/07/1999US5998194 Polyketide-associated sugar biosynthesis genes
12/07/1999US5998191 Diagnosis kit
12/07/1999US5998190 Culture product
12/07/1999US5998182 Mixing a aerococcus bacteria strain
12/07/1999US5998180 Culture product
12/07/1999US5998173 Process for producing N-acetyl-D-glucosamine
12/07/1999US5998172 Anti-CD6 ligand antibodies
12/07/1999US5998166 Human cd16-ii variants, dna sequences coding for them, their use in therapy and/or in diagnosis of autoimmune diseases and inflammatory illnesses.
12/07/1999US5997882 Epitopic regions of pneumococcal surface protein A
12/07/1999US5997870 Isolated peptides which bind to HLA-B44 Molecules
12/07/1999US5997867 Method of using humanized antibody against CD18
12/07/1999US5997269 Means for discovering microbes
12/07/1999CA2189581C Ice and ice-like compositions and methods of making same
12/07/1999CA2119773C Macrophage activating factor from animal vitamin d-binding protein
12/07/1999CA2074943C Process for the enzymatic cleavage of recombinant proteins using iga proteases
12/07/1999CA2073288C Manipulation of gene copy number in bordetella
12/07/1999CA1340846E Expression of biologically active platelet derived growth factor analogs in eucaryotic cells
12/07/1999CA1340841C Cecropin-like polypeptides with activity against gram-positive and gram-negative bacteria
12/07/1999CA1340839C Proteins and process for preparing them, dna sequences, antibodies and uses thereof, posvirus, altered or infected cells, pharmaceutical compositions useful for the prevention of schistosomosis and uses thereof as an agent with a glutathion-s-transferase activity
12/07/1999CA1340838C Coccidiosis vacine
12/07/1999CA1340837C Expression and secretion of heterologous proteins by yarrowia lipolytica transformants
12/02/1999WO1999061667A1 Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams
12/02/1999WO1999061648A1 Process for producing l-ribose
12/02/1999WO1999061646A1 Improved process for alcoholic fermentation
12/02/1999WO1999061645A1 Novel compound, wf00144
12/02/1999WO1999061638A1 Chimeric adenoviral vectors
12/02/1999WO1999061634A1 Method of producing thy a-strains of vibrio cholerae, such strains and their use
12/02/1999WO1999061627A2 Mutant lactobacillus bulgaricus strains free from beta-galactoside activity
12/02/1999WO1999061625A1 Mycobacterial n-acetyltransferases
12/02/1999WO1999061624A2 Polyhydroxyalkanoate biopolymer compositions
12/02/1999WO1999061611A1 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
12/02/1999WO1999061604A2 A vector for gene trap, and a method for gene trapping by using the vector
12/02/1999WO1999061592A1 Novel endonuclease of immune cell, process for producing the same and immune adjuvant using the same
12/02/1999WO1999061453A2 priA
12/02/1999WO1999061399A1 Genes encoding epsilon lycopene cyclase and method for producing bicyclic epsilon carotene
12/02/1999WO1999050413A3 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
12/02/1999WO1999032634A3 Compositions derived from mycobacterium vaccae and methods for their use
1 ... 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 ... 921